As a potential ligand of EGFR, EGFL6 could downregulate the expression of E-cadherin, upregulate the expression of F-actin and Vimentin, and promote metastasis of nasopharyngeal carcinoma through the EMT signal pathway (41). Here, CDH1 is linked to nasopharyngeal carcinoma.